In Brief: Prestige Buys Insight, Quarterly Earnings For MJN And Colgate, Bio-Recovery Warned On Claims
This article was originally published in The Tan Sheet
Executive Summary
Prestige acquires Insight Pharmaceuticals; Product relaunches boost Novartis’ consumer sales; Colgate’s N.A. sales inch up; Mead Johnson sales up 7%; and Bio-Recovery makes drug claims.
You may also be interested in...
Prestige Brands Prepares To Weather Retailers' Inventory Storm
The firm's sales of BC, Goody's, Monistat and other consumer health care brands grow 4.3% in North America and 17.8% internationally in its latest quarter. CEO Ron Lombardi says Prestige Brands expects lower volume orders from retailers during the current quarter and early 2017.
Prestige Brands Prepares To Weather Retailers' Inventory Storm
The firm's sales of BC, Goody's, Monistat and other consumer health care brands grow 4.3% in North America and 17.8% internationally in its latest quarter. CEO Ron Lombardi says Prestige Brands expects lower volume orders from retailers during the current quarter and early 2017.
Prestige Brands Invests $111m To Boost Advertising From Market Research
Prestige Brands supports leading brands including Monistat and Dramamine with promotional campaigns stemming from research into consumer preferences, says sales and marketing head Timothy Connors. With $111m ad spend, it aims to become a “preeminent marketing and sales” firm.